EarningsQ2 2026 Earnings Report

Cannara Biotech (8CB0) Q2 2026 Earnings Report

0 Followers

DE:8CB0 Q2 2026 EPS Results

Actual EPS€0.01

Consensus EPS€0.03

Beat/MissMissed by -€0.02

One Year Ago EPS€0.02

Actual Revenue€16.86M

Expected Revenue€19.67M

Beat/MissMissed by -€2.80M

YoY Revenue Growth+2.23%

QuarterQ2 2026

Date04/14/2026

TimeBefore Open

Conference CallTuesday, April 14, 2026

DE:8CB0 Upcoming Earnings

Cannara Biotech's next earnings date is estimated for November 24, 2026, based on past reporting schedules.

DE:8CB0 Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 24, 2026	2026 (Q4)	0.02 / -	0.025	―
Jul 15, 2026	2026 (Q3)	0.03 / 0.03	0.025	25.00% (<+0.01)
Apr 14, 2026	2026 (Q2)	0.03 / 0.01	0.023	-45.95% (-0.01)
Jan 26, 2026	2026 (Q1)	- / <0.01	0.016	-61.54% (>-0.01)
Nov 24, 2025	2025 (Q4)	- / 0.02	0.04	-37.50% (-0.01)
Jul 28, 2025	2025 (Q3)	- / 0.02	0.014	81.82% (+0.01)
Apr 28, 2025	2025 (Q2)	- / 0.02	-0.024	197.37% (+0.05)
Jan 27, 2025	2025 (Q1)	- / 0.02	0.014	13.04% (<+0.01)
Nov 25, 2024	2024 (Q4)	- / 0.04	0.032	25.49% (<+0.01)
Jul 23, 2024	2024 (Q3)	- / 0.01	0.02	-33.33% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed